Delflex NDC 49230-188

NDC codes

FDA NDC Directory

Product NDC (as listed)49230-188Labeler and product segments. Claims need a package NDC.

Product NDC at billing width49230-0188Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
49230-188-50	49230018850	2 BAG in 1 CARTON (49230-188-50) / 5000 mL in 1 BAGMarketed from Nov 30, 1984
49230-188-52	49230018852	2 BAG in 1 CARTON (49230-188-52) / 5000 mL in 1 BAGMarketed from Nov 30, 1984
49230-188-62	49230018862	2 BAG in 1 CARTON (49230-188-62) / 6000 mL in 1 BAGMarketed from Nov 30, 1984

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Delflex
Generic name (nonproprietary): dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
Active ingredients: Dextrose monohydrate — 1.5 g/100mLSodium chloride — 567 mg/100mLSodium lactate — 392 mg/100mLCalcium chloride — 25.7 mg/100mLMagnesium chloride — 15.2 mg/100mL
Dosage form: Solution
Route: Intraperitoneal
Labeler: Fresenius Medical Care Renal Therapies Group, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018883
Marketing start: Nov 30, 1984
Listing expires: Dec 31, 2027
Other FDA classes: Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 49230-188_595790f1-c143-5ae9-e063-6294a90abd18SPL ID 595790f1-c143-5ae9-e063-6294a90abd18SPL set ID 515dcee0-3e34-11e2-a25f-0800200c9a66UNII M4I0D6VV5M, TU7HW0W0QT, LX22YL083G, 02F3473H9O, 451W47IQ8X
Pharmacologic class: Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N449230018850 followed by a unit qualifier and the quantity

Package 49230-0188-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 18, 2026.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE DELFLEX® is indicated in the treatment of chronic kidney failure in patients being maintained on peritoneal dialysis. For treatment of chronic kidney failure. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 018883

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018883
Product	Strength	Form · route	Labeler	Product NDC
Delflexdextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride	Dextrose monohydrate 2.5 g/100mL + 4 more ingredients	SolutionIntraperitoneal	Fresenius Medical Care Renal Therapies Group, LLC	49230-191